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For their work on the development of the modern cochlear implant, which bestows hearing to
individuals with profound deafness, Ingeborg Hochmair, Graeme Clark, and Blake Wilson are the
2013 recipients of the LaskerDeBakey Clinical Medical Research Award.Ingeborg Hochmair, Graeme Clark, and
Blake Wilson each lead a team of profes-
sionals dedicated to aiding the many indi-
viduals with hearing impairment. The
Lasker Foundation now recognizes their
scientific contributions to the develop-
ment of cochlear implants, and in so doing
acknowledges the effort of many individ-
uals, both past and present, in the field
of cochlear implantation, widely recog-
nized as one of the most successful
achievements in modern medicine.
Cochlear implants now routinely make it
possible for young congenitally deaf
children to communicate orally and
restores aspects of hearing for many
adults who lose their hearing later in life.
Cochlear implants represent the first
technology to successfully replace and
augment a biologic sense organ (Loizou,
1999). The device consists of internal
and external hardware that use a micro-
phone to collect acoustic signals, pro-
cess the signal using sophisticated
software to decompose, and translate
the signal into electrical pulses that can
be transmitted to a surgically implanted
electrode array placed in the cochlea.
These signals stimulate the auditory
nerve, and the brain learns to interpret
the signals as speech or other sounds.
Cochlear implants assist many individuals
who are totally deaf or very nearly totally
deaf to engage in conversational speech
without using visual cues. A high per-
centage of cochlear implant recipients
converse by speaking and listening,
including talking on the telephone, with
little difficulty.
To date, over 300,000 severely or
profoundly hearing impaired individualshave received cochlear implants world-
wide. For many of these individuals,
cochlear implants provide a substantial
increase in their quality of life by opening
up a large universe of employment and
recreational opportunities. Consequently,
the cost-benefit ratio for cochlear implan-
tation is extremely high, exceeding by a
large margin the cost benefit of many
commonly performed medical proce-
dures, including total hip replacements
(Wyatt et al., 1996).
Recently, several review articles have
been published exploring and document-
ing the historical road traveled to develop
cochlear implants (Clark, 2008; Wilson
et al., 2011). Common themes among
these historical reviews include recog-
nizing the contributions made in the late
1700s by individuals who invented elec-
tricity via a capacitor system, the Leyden
jar, or via early batteries. Early publica-
tions from individuals, such as Volta, pro-
vide important glimpses into man’s initial
fascination with electricity and its possible
interaction with the body. Accounts of the
social impact of deafness on individuals
during these early periods often reflect
back to the poignant words and experi-
ences of Ludwig van Beethoven and
Helen Keller who experienced significant
hearing losses. Beethoven, in letters to
his brothers, wrote, ‘‘For me there can
be no relaxation in human society; no
refined conversations, no mutual confi-
dences. I must live quite alone and may
creep into society only as often as sheer
necessity demands. Such experiences
almost made me despair and I was on
the point of putting an end to my life—
the only thing that held me back was myCell 154, Separt. [And] thus I have dragged on this
miserable existence’’ (Lockwood, 2003).
Helen Keller stated, ‘‘I am just as deaf
as I am blind. The problems of deafness
are deeper and more complex, if not
more important, than those of blindness.
Deafness is a much worse misfortune.
For it means the loss of the most vital
stimulus—the sound of the voice that
brings language, sets thoughts astir and
keeps us in the intellectual company of
man’’ (Keller, 1933).
Djourno and Eyries (1957) were the first
to report that electrical current passed
through the auditory nerve produced an
auditory sensation. During the early
1960s, several investigators, including
William House and Blair Simmons, led
teams investigating electrical stimulation
of the auditory nerve (Mudry and Mills,
2013). Subjects not only experienced an
auditory percept but showed some ability
to distinguish differences in sounds of
different frequencies. House placed a
single ball electrode inside the cochlea
to stimulate the auditory nerve. The
majority of individuals receiving this
single-channel cochlear implant per-
ceived environmental sounds and distin-
guished differences between many of
them. Complex spectral discrimination,
however, remained poor by current day
standards, and few individuals recog-
nized words or understood complex
spoken language. House was, however,
able to demonstrate that auditory per-
cepts generated by electrical signals
from the implanted device significantly
enhanced lip reading and, thereby,
enhanced the ability to communicate.
House’s early efforts were met with greattember 12, 2013 ª2013 Elsevier Inc. 1175
Figure 1. Cochlear Implants
(A and B) Two microdissected cochleae. The bone over scala vestibule has
been removed, and one can see through the osseous spiral lamina and basilar
membrane into scala tympani. The specimen in (B) has had two segments of
the osseous spiral lamina and the basilar membrane removed so that one can
see directly into scala tympani. In both specimens, one can see a silicon
embedded multichannel electrode (stained blue). Separate contacts are used
to stimulate the neural elements with the output from separate channels
representing different parts of the frequency spectrum. (A) This specimen has
an electrode that lies along the lateral wall of scala tympani (ST) immediately
under the basilar membrane (M), lateral to the osseous spiral lamina (OL). (B)
This specimen has an electrode tightly curled against the modiolus (the medial
wall of scala tympani). Both types of placement are used in currently available
cochlear implants and debate continues as to which placement is best.
Photograph courtesy of Charles Gary Wright, UT Southwestern Medical
Center, Dallas, Texas.skepticism; he performed his
work with little encourage-
ment and in the face of some
hostility. Whilemost early pro-
ponents believed cochlear
implants would restore some
useful hearing for adult recipi-
ents who lost their hearing
after they acquired language,
most proponents believed
that implants would have
limited to no role in the man-
agement of children with con-
genital deafness. Yet, one of
the most important achieve-
ments of current cochlear
implant technology is the
ability to restore aspects of
hearing to many congenitally
deaf children who conse-




stimulation of the cochlear
nerve would never permitspeech understanding. Cochlear implants
achieved scientific ‘‘legitimacy’’ in 1975
when the National Institute of Health
sponsored the research studies under-
taken by Bilger and his colleagues.
The resulting ‘‘Bilger Report’’ confirmed
some speech perception benefit of
cochlear implantation in 13 subjects.
The history of the development of
cochlear implants can be divided into
four steps: (1) proof of concept—it had
to be shown that electrical stimulation of
the auditory nerve in hearing impaired
persons produced a useful auditory
percept; (2) development of devices that
could be safely implanted by a variety of
surgeons with minimal risk and which
could be tolerated by recipients for
many years without damaging the audi-
tory system or surrounding structures;
(3) development of devices that used the
tonotopic organization of the cochlea
to allow the recipient to discriminate
between pitches; (4) development of
algorithms that converted auditory signals
into pulse trains to stimulate multiple sites
and maximize speech recognition.
Many of the principal contributors to
step 1, including Djourno, Eyrie´s, House,
and Simmons, are now deceased. Critical
contributions for step 2 were made by the
Hochmair team. The Hochmair and Clark1176 Cell 154, September 12, 2013 ª2013 Elteams working separately achieved
step 3, and Wilson and his team devel-
oped the speech coding strategies critical
for step 4.
Hochmair’s leadership initially focused
on developing reliable cochlear implant
systems that used a single site of stimula-
tion either within or just outside the
cochlea. These devices were well toler-
ated and allowed limited speech recogni-
tion. The Med-El Corporation (Innsbruck,
Austria), now the second largest commer-
cial provider of cochlear implants, was
founded by Hochmair and developed the
first system providing a behind-the-ear
processor and associated transmitting
coil. Her team is known for rigorous phys-
ical studies and Med-El Corporation has
supported fundamental and clinical re-
search at leading universities throughout
the world. The behind-the-ear processor
made cochlear implants desirable to a
variety of recipients and is used by many
devices today. Hochmair also was pivotal
for step 3. Her team developed active
electrodes in an implanted stimulator/
receiver and an array of electrodes
imbedded in a silicone carrier. As shown
in Figure 1, electrode design and place-
ment are critical for successful cochlear
implantation. These two fundamental
design features are still used by currentlysevier Inc.marketed devices. A system
with these features was first
implanted in Vienna on
December 16, 1977.
A similar system was
implanted by Clarke’s team
in Melbourne in August of
1978. Clarke and his team of
scientists and clinicians in-





processing. In addition, his
investigators have explored
how the devices influence
communication development.
Clark’s teams have produced
the highest number of publi-
cations from a single institu-
tion in cochlear implantation
across the world and made
many important scientific dis-
coveries advancing the field.
His teams have also exploredapplying knowledge obtained from
cochlear implants to other sensory sys-
tems, notably the tactile system, through
his ‘‘Tickle Talker.’’ Clark’s devices are
marketed by Cochlear Corporation
(Sydney, Australia) which continues to
support research around the world,
including in Australia, to further develop
the implant devices.
Wilson spent the majority of his career
working at the Research Triangle Park in
North Carolina and received his principle
funding through a continuous series of
National Institutes of Health grants and
contracts. In 1991, Wilson developed a
new method of encoding acoustic infor-
mation into electrical impulses, which
permitted much improved speech recog-
nition. This speech coding strategy was
termed continuous interleaved sampling
(CIS). This development was reported in
Nature in 1991 and remains the most
highly cited publication in the field of
cochlear implants (Wilson et al., 1991).
CIS is still used as a processing option in
all the cochlear implant systems manu-
factured by the ‘‘big three’’ cochlear
implant companies, which reach more
than 99% of the global market. Other
speech coding strategies are available,
but the majority are either the same or
refinements of those described by Wilson
and his team over the years. All the intel-
lectual property developed by Wilson
and his team has been donated to the
public domain.
As one would expect, a large number
of individuals made contributions in the
development of cochlear implants. In
this paragraph, we will mention only a
few of the others. Donald Eddington, for
example, working at the University of
Utah, made critical advances in the devel-
opment of implants that stimulated mul-
tiple sites. Eddington’s work was critical
in the design of the Symbion and Ineraid
cochlear implants, which, at one point,
had individuals with the highest speech
recognition scores. Because the Ineraid
had a transcutaneous port that permitted
access to and manipulation of the internal
components, Ineraid patients were highly
sought as research subjects long after
manufacture of the device was discon-
tinued. Michael Merzenich also made
important contributions in the area of
neuroplasticity. Working together with
Robin Michelson and Robert Schindler
at the University of California, Merzenich
completed important work developing
the Advanced Bionics device. Advanced
Bionics Corporation (Valencia, CA) hasnow become the third largest manufac-
turer of cochlear implants.
As indicated by the Lasker Foundation
Award, cochlear implants represent a
technology that brings sound to many
individuals who otherwise would experi-
ence diminished or absent sound in their
environments. The field continues to
grow and flourish as individuals around
theworld designmore sophisticated elec-
trodes, improve surgical techniques,
develop smaller and more efficient hard-
ware, document the communication
benefits achieved by young children
using the devices, explore methods of
enhancing the coding of tonal languages,
improve the processing of speech in noisy
environments, explore whether perfor-
mance is further enhanced with two
versus a single cochlear implant, inquire
whether the devices would provide equal
or greater benefit to individuals with
greater amounts of residual hearing who
use conventional hearing aids, determine
the optimal age to implant young children,
and to explore the importance of habilita-
tion intervention programs in further
enhancing the benefits provided to
communication by the devices. The entire
field congratulates Ingeborg Hochmair,Cell 154, SepGraeme Clark, and Blake Wilson on their
leadership and contributions to the field
of cochlear implantation. The contribu-
tions made by their teams of investigators
to the field of cochlear implantation are
well deserving of the 2013 Lasker Foun-
dation Award.REFERENCES
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